Improving recovery after stroke: A role for antidepressant medications?

Stroke

Volumn 43, Issue 10, 2012, Pages 2829-2832

  Adams, Harold P ^a   Robinson, Robert G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

antidepressant medications; selective serotonin reuptake inhibitors; stroke recovery

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; ATTENTION; BONE MARROW CELL; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONVALESCENCE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EARLY INTERVENTION; HUMAN; MEMORY; PHYSIOTHERAPY; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEM CELL TRANSPLANTATION; STROKE; STROMA CELL;

EID: 84866713302     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.640524     Document Type: Article

References (56)

1. Kleindorfer D, Xu Y, Moomaw CJ, Khatri P, Adeoye O, Hornung R. US geographic distribution of rtPA utilization by hospital for acute ischemic stroke. Stroke. 2009;40:3580-3584.
2. National Institute of Neurological Disorders and Stroke. Post-Stroke Rehabilitation Fact Sheet. NIH Publication 80-4846. Bethesda, MD: National Institute of Neurological Disorders and Stroke; 2008.
3. Robinson RG, Adams HP Jr. Selective serotonin-reuptake inhibitors and recovery after stroke. Lancet Neurol. 2011;10:110-111.
4. Cramer SC. Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery. Int J Stroke. 2011;6:315-316.
5. Cramer SC. Reparing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann Neurol. 2008;63:272-287. (Pubitemid 351499857)
6. Cramer SC. Repairing the human brain after stroke. II. Restorative therapies. Ann Neurol. 2008;63:549-560.
7. Cramer SC. Brain repair after stroke. N Engl J Med. 2010;362: 1827-1829.
8. Johansson BB. Environmental effects on functional outcome after stroke. In: Cramer SC, Nudo RJ, eds. Brain Repair After Stroke. Cambridge, UK: Cambridge University Press; 2010:47-55.
9. Carmichael ST. Molecular mechanisms of neural repair after stroke. In: Cramer SC, Nudo RJ, eds. Brain Repair After Stroke. Cambridge, UK: Cambridge University Press; 2010:11-21.
10. Chopp M, Li Y, Zhang ZG. Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies. Stroke. 2009;40:S143-S145.
11. Rossini PM, Calautti C, Pauri F, Baron JC. Post-stroke plastic reorganisation in the adult brain. Lancet Neurol. 2003;2:493-502. (Pubitemid 36876106)
12. Jones T, Allred R, Adkins D, Hsu JE, O'Bryant A, Maldonado M. Remodeling the brain with behavioral experience after stroke. Stroke. 2009;40:S136-S138.
13. Jones TA, Adkins DL. Behavioral influence on neuronal events after stroke. In: Cramer SC, Nudo RJ, eds. Brain Repair After Stroke. Cambridge, UK: Cambridge University Press; 2010:23-33.
14. Marti-Fabregas J, Romaguera-Ros M, Gomez-Pinedo U, Martinez-Ramirez S, Jimenez-Xarrie E, Marin R, et al. Proliferation in the human ipsilateral subventricular zone after ischemic stroke. Neurology. 2010;74: 357-365.
15. Teskey GC, Kolb B. Post-stroke recovery therapies in animals. In: Cramer SC, Nudo RJ, eds. Brain Repair After Stroke. Cambridge, UK: Cambridge University Press; 2010:35-45.
16. Fisher M, Finkelstein S. Pharmacological approaches to stroke recovery. Cerebrovasc Dis. 1999;9(suppl 5):29-32. (Pubitemid 29410706)
17. Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009;8:491-500.
18. Caplan LR, Arenillas J, Cramer SC, Joutel A, Lo EH, Meschia J, et al. Stroke-related translational research. Arch Neurol. 2011;68:1110-1123.
19. Loubinoux I, Chollet F. Neuropharmacology in stroke recovery. In: Cramer SC, Nudo RJ, eds. Brain Repair After Stroke. Cambridge, UK: Cambridge University Press; 2010:183-193.
20. Rosser N, Floel A. Pharmacological enhancement of motor recovery in subacute and chronic stroke. Neurorehabilitation. 2008;23:95-103. (Pubitemid 352038566)
21. Liepert J. Pharmacotherapy in restorative neurology. Curr Opin Neurol. 2008;21:639-643.
22. Lokk J, Roghani RS, Delbari A. Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke-a randomized, double-blind, placebo-controlled trial. Acta Neurol Scand. 2010;123:266-273.
23. Zorowitz RD, Smout RJ, Gassaway JA, Horn SD. Neurostimulant medication usage during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP). Top Stroke Rehabil. 2005;12:28-36. (Pubitemid 43132701)
24. Paolucci S, Gandolfo C, Provinciali L, Torta R, Toso V, DESTRO Study Group. The Italian multicenter observational study on post-stroke depression (DESTRO). J Neurol. 2006;253:556-562. (Pubitemid 43876983)
25. Platz T. Depression and its effects after stroke. In: Cramer SC, Nudo RJ, eds. Brain Repair After Stroke. Cambridge, UK: Cambridge University Press; 2010:145-161.
26. Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative Study. Arch Intern Med. 2009;169:2128-2139.
27. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551.
28. Wu C-S, Wang S-C, Cheng YC, Gau SS. Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry. 2011;168:511-521.
29. Douglas IJ, Smeeth L, Irvine D. The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. Br J Clin Pharmacol. 2011;71:116-120.
30. Trifiro G, Dieleman J, Sen EF, Gambassi G, Stukenboom MC. Risk of ischemic stroke associated with antidepressant drug use in elderly persons. J Clin Psychopharmacol. 2010;30:252-258.
31. Almeida OP, Alfonso H, Hankey GJ, Flicker L. Depression, antidepressant use and mortality in later life: the Health in Men Study. PLoS One. 2010;e11266.
32. Almeida OP, Waterreus A, Hankey GJ. Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry. 2006;67:1104-1109. (Pubitemid 44230882)
33. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity. JAMA. 2011;303:47-53.
34. Isacsson G, Adler M. Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression. Acta Psychiatr Scand. 2012;125:423-424.
35. Hackett ML, Hill KM, Hewison J, Anderson CS, House AO; on behalf of the Auckland Regional Community Stroke. Stroke survivors who score below threshold on standard depression measures may still have negative cognitions of concern. Stroke. 2010;41:478-481.
36. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008;4:CD003437.
37. Yi ZM, Liu F, Zhai SD. Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis. Int J Clin Pract. 2010;64:1310-1317.
38. Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, et al. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient. Stroke. 2010;41:2402-2448.
39. Bilge C, Kocer E, Kocer A, Turk Boru U. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Eur J Phys Rehabil Med. 2008;44:13-18.
40. Narushima K, Robinson RG. The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression. Is there a time-related therapeutic window? J Nerv Ment Dis. 2003;191: 645-652. (Pubitemid 37296176)
41. Tallelli P, Werring DJ. Pharmacological augmentation of motor recovery after stroke: antidepressants for non-depressed patients? J Neurol. 2009; 256:1159-1160.
42. Mikami K, Jorge RE, Adams HP Jr., Davis PH, Leira EC, Jang M, Robinson RG. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry. 2011;19:1007-1015.
43. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA. 2008;299:2391-2400. (Pubitemid 351749237)
44. Chollet F, Tardy J, Albucher J-F, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123-130.
45. Lim CM, Kim SW, Park JY, Kim C, Yoon SH, Lee JK. Fluoxetine affords robust neuroprotection in the postischemic brain via its antiinflammatory effect. J Neurosci Res. 2009;87:1037-1045.
46. Malberg J, Schechter E. Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs. Curr Pharm Des. 2005;11:145-155. (Pubitemid 40089838)
47. Newton SS, Duman RS. Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS Drugs. 2007;21:715-725. (Pubitemid 47294718)
48. Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 2009;27: 1211-1214.
49. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke depression-a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol. 2009;250:347-351.
50. Pariente J, Loubinoux I, Carel C, Albucher J-F, Leger A, Manelfe C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol. 2001;50:718-729. (Pubitemid 33116131)
51. Wang LE, Fink GR, Diekhoff S, Rehme AK, Eickhoff SB, Grefkes C. Noradrenergic enhancement improves motor network connectivity in stroke patients. Ann Neurol. 2011;69:375-378.
52. Zittel S, Weiller C, Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair. 2009;22:311-314. (Pubitemid 351561669)
53. Acler M, Robol E, Fiaschi A, Manganotti P. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol. 2009;256: 1152-1158.
54. Loubinoux I, Pariente J, Boulanouar K, Carel C, Anelfe C, Ascol O, et al. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, MRI study in healthy subjects. Neuroimage. 2009;15:26-36.
55. Jorge RE, Acion L, Moser D, Adams HP Jr., Robinson RG. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry. 2010;67:187-196.
56. Simis S, Nitrini R. Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke. Arq Neuropsiquiatr. 2009;64:412-417. (Pubitemid 44252324)